本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

28.13
-0.5200-1.82%
盘后28.500.3700+1.32%17:29 EDT
成交量:281.01万
成交额:7,960.38万
市值:35.53亿
市盈率:-15.42
高:28.97
开:28.84
低:27.85
收:28.65
52周最高:41.94
52周最低:16.10
股本:1.26亿
流通股本:7,811.99万
量比:1.47
换手率:3.60%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
净资产收益率:-108.49%
总资产收益率:-13.77%
市净率:22.73
市盈率(LYR):-17.61

数据加载中...

2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities